180 related articles for article (PubMed ID: 12885730)
1. Vascular radiation in a drug-eluting stent world: it's not over till it's over.
Teirstein PS; King S
Circulation; 2003 Jul; 108(4):384-5. PubMed ID: 12885730
[No Abstract] [Full Text] [Related]
2. Vascular brachytherapy boon or bust?
Kereiakes DJ; Willerson JT
Circulation; 2003 Jul; 108(4):389-90. PubMed ID: 12885732
[No Abstract] [Full Text] [Related]
3. Coronary brachytherapy in the drug-eluting stent era: don't bury it alive.
Waksman R; Weinberger J
Circulation; 2003 Jul; 108(4):386-8. PubMed ID: 12885731
[No Abstract] [Full Text] [Related]
4. The future of CART in the era of drug eluting stents: "It's not over until it's over". Counterpoint.
Tripuraneni P
Brachytherapy; 2003; 2(2):74-6. PubMed ID: 15062143
[No Abstract] [Full Text] [Related]
5. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent in patients with diabetes mellitus.
Finn AV; Gold HK
Circulation; 2004 Sep; 110(12):e318-9; author reply e318-9. PubMed ID: 15381668
[No Abstract] [Full Text] [Related]
6. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis.
Torguson R; Sabate M; Deible R; Smith K; Chu WW; Kent KM; Pichard AD; Suddath WO; Satler LF; Waksman R
Am J Cardiol; 2006 Nov; 98(10):1340-4. PubMed ID: 17134625
[TBL] [Abstract][Full Text] [Related]
7. [Past, present, and future of intracoronary brachytherapy].
Angiolillo DJ; Sabaté M
Ital Heart J Suppl; 2003 Oct; 4(10):794-806. PubMed ID: 14664291
[TBL] [Abstract][Full Text] [Related]
8. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation.
Chu WW; Torguson R; Pichard AD; Satler LF; Chan R; Porrazzo M; Kent KM; Suddath WO; Waksman R
J Invasive Cardiol; 2005 Dec; 17(12):659-62. PubMed ID: 16327049
[TBL] [Abstract][Full Text] [Related]
9. Understanding the drug-eluting stent trials.
Coolong A; Kuntz RE
Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
[TBL] [Abstract][Full Text] [Related]
10. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials.
Mauri L; Orav EJ; Candia SC; Cutlip DE; Kuntz RE
Circulation; 2005 Nov; 112(18):2833-9. PubMed ID: 16267256
[TBL] [Abstract][Full Text] [Related]
11. Optimal treatment for in-stent restenosis after BMS--DES, coated balloon, or scalpel?
Mukherjee D
Eur Heart J; 2008 Jul; 29(13):1595-6. PubMed ID: 18556717
[No Abstract] [Full Text] [Related]
12. TOR of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent?
Carter AJ
Catheter Cardiovasc Interv; 2004 Feb; 61(2):233-6. PubMed ID: 14755819
[No Abstract] [Full Text] [Related]
13. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
[TBL] [Abstract][Full Text] [Related]
14. Critical role of bare-metal stent controls in trials of drug-eluting stents.
Biondi-Zoccai GG; Agostoni P; Abbate A; Airoldi F; Colombo A
Eur Heart J; 2005 Aug; 26(16):1686-7; author reply 1687. PubMed ID: 15946954
[No Abstract] [Full Text] [Related]
15. Vascular brachytherapy vs. drug-eluting stents for the treatment of in-stent restenosis: the jury's still out.
Waksman R
Catheter Cardiovasc Interv; 2004 Jul; 62(3):290-1. PubMed ID: 15224291
[No Abstract] [Full Text] [Related]
16. Intracoronary brachytherapy following drug-eluting stent failure. It's still not time to hang up the spikes!
Angiolillo DJ; Sabaté M; Jiménez-Quevedo P; Alfonso F; Galván C; Fernández JM; Hernandez-Antolin R; Escaned J; Bañuelos C; Moreno R; Macaya C
Cardiovasc Radiat Med; 2003; 4(4):171-5. PubMed ID: 15321053
[TBL] [Abstract][Full Text] [Related]
17. Drug-eluting stents: from randomized trials to the real world.
Saia F; Degertekin M; Lemos PA; Serruys PW
Minerva Cardioangiol; 2004 Oct; 52(5):349-63. PubMed ID: 15514571
[TBL] [Abstract][Full Text] [Related]
18. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of drug-eluting stents: current best available evidence.
Raja SG; Dreyfus GD
J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
[TBL] [Abstract][Full Text] [Related]
20. The drug-eluting stent dilemma: comparing the effectiveness of Cypher versus Taxus.
Biondi-Zoccai GG; Agostoni P; Sangiorgi GM; Colombo A
J Cardiovasc Med (Hagerstown); 2006 Jan; 7(1):2-4. PubMed ID: 16645353
[No Abstract] [Full Text] [Related]
[Next] [New Search]
